» Articles » PMID: 21143282

Functions of Angiotensin Peptides in the Rostral Ventrolateral Medulla

Overview
Specialties Pharmacology
Physiology
Date 2010 Dec 15
PMID 21143282
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

1. It was first shown several years ago that the rostral part of the ventrolateral medulla (VLM) contains a high density of receptor binding sites for angiotensin II (AngII). In the present paper we briefly review recent studies aimed at determining the actions of both exogenous and endogenous angiotensin peptides in the rostral VLM, as well as their specific sites of action. 2. The results of these studies have shown that angiotensin peptides can excite pressor and sympathoexcitatory neurons in the rostral VLM, but do not appear to affect non-cardiovascular neurons in this region. 3. It is known that pressor neurons in the rostral VLM include both catecholamine and non-catecholamine neurons. There is evidence that, at least in conscious rabbits, both of these types of neurons are activated by AngII. The specific endogenous angiotensin peptide or peptides that affect pressor neurons in the rostral VLM have not yet been definitively identified. 4. It is also possible that different angiotensin peptides may have different effects on pressor neurons in the rostral VLM, mediated by different receptors. Further studies will be needed to define these different functions as well as the specific receptors and cellular mechanisms that subserve them.

Citing Articles

The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Wright J, Harding J Pflugers Arch. 2012; 465(1):133-51.

PMID: 22535332 DOI: 10.1007/s00424-012-1102-2.


Rhythmic activity of neurons in the rostral ventrolateral medulla of conscious cats: effect of removal of vestibular inputs.

Barman S, Sugiyama Y, Suzuki T, Cotter L, DeStefino V, Reighard D Am J Physiol Regul Integr Comp Physiol. 2011; 301(4):R937-46.

PMID: 21734018 PMC: 3197344. DOI: 10.1152/ajpregu.00265.2011.


The renin-angiotensin system in the brain: possible therapeutic implications for AT(1)-receptor blockers.

Culman J, Blume A, Gohlke P, Unger T J Hum Hypertens. 2002; 16 Suppl 3:S64-70.

PMID: 12140731 DOI: 10.1038/sj.jhh.1001442.